Dr Victor Dieriks
@vdieriks.bsky.social
Neuroscientist focusing on Parkinson’s disease and multiple system atrophy. Group leader Synuclein Lab at the University of Auckland, New Zealand, love hiking, trail running and watching sunsets.
Dierikslab.com
Dierikslab.com
🧠🌍 Quiz Time!
Take a close look at this image: 🗺️
❓ Can you name these three countries?
Hint: They share a surprising connection to Parkinson's disease.
Drop your answers below and let's discuss! 🧬🗨️
#Parkinsons #HealthQuiz
Take a close look at this image: 🗺️
❓ Can you name these three countries?
Hint: They share a surprising connection to Parkinson's disease.
Drop your answers below and let's discuss! 🧬🗨️
#Parkinsons #HealthQuiz
January 15, 2025 at 8:48 AM
🧠🌍 Quiz Time!
Take a close look at this image: 🗺️
❓ Can you name these three countries?
Hint: They share a surprising connection to Parkinson's disease.
Drop your answers below and let's discuss! 🧬🗨️
#Parkinsons #HealthQuiz
Take a close look at this image: 🗺️
❓ Can you name these three countries?
Hint: They share a surprising connection to Parkinson's disease.
Drop your answers below and let's discuss! 🧬🗨️
#Parkinsons #HealthQuiz
3/4 We've pioneered a new antigen retrieval protocol: 'Cyclic Heat-Induced Epitope Retrieval (CHIER).' This innovative method significantly boosts the detection of SMARCC2 cytobodies, without compromising the integrity of other epitopes. 🧪🔬
December 19, 2024 at 5:12 AM
3/4 We've pioneered a new antigen retrieval protocol: 'Cyclic Heat-Induced Epitope Retrieval (CHIER).' This innovative method significantly boosts the detection of SMARCC2 cytobodies, without compromising the integrity of other epitopes. 🧪🔬
2/4 SMARCC2, known for its role in chromatin remodelling and transcription regulation, forms unique honeycomb-structured cytobodies in neurons. Our findings show an increase in these cytobodies in Parkinson's Disease, suggesting a potential role in early disease progression.
December 19, 2024 at 5:12 AM
2/4 SMARCC2, known for its role in chromatin remodelling and transcription regulation, forms unique honeycomb-structured cytobodies in neurons. Our findings show an increase in these cytobodies in Parkinson's Disease, suggesting a potential role in early disease progression.
The diversity in α-Syn strains, truncations, and post-translational modifications contributes to the variability observed in these disorders. The critical point at which α-Syn aggregation shifts from a consequence to a driving force in disease progression remains unknown.
December 16, 2024 at 3:31 AM
The diversity in α-Syn strains, truncations, and post-translational modifications contributes to the variability observed in these disorders. The critical point at which α-Syn aggregation shifts from a consequence to a driving force in disease progression remains unknown.
How can a single protein orchestrate a vast array of diseases from early development to advanced age?
December 16, 2024 at 3:31 AM
How can a single protein orchestrate a vast array of diseases from early development to advanced age?